Academic Background: Ph.D. in Biological Chemistry and Molecular Pharmacology, Harvard University, 1989; B.A. in Chemistry, Pomona College, 1985.
Research Interests: CRISPR-Cas9 gene editing, RNA biology, molecular mechanisms of gene regulation, and applications in biotechnology and medicine.
Appointments: Li Ka Shing Chancellor’s Chair Professor, Department of Chemistry and Molecular and Cell Biology, UC Berkeley; Investigator, Howard Hughes Medical Institute (1997–present).
Awards: Nobel Prize in Chemistry (2020, shared with Emmanuelle Charpentier); Breakthrough Prize in Life Sciences (2015); Japan Prize (2017).
Publications:
Editorial Contributions: Editorial board member, Science and Cell.
Additional Contributions: Co-founder, Caribou Biosciences and Intellia Therapeutics; public advocate for ethical use of gene editing.